Literature DB >> 22665363

Fuel, electricity, ER and HER2--a hybrid-car model of breast cancer.

Shigehira Saji, Fumiaki Sato, Naoto T Ueno.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22665363     DOI： 10.1038/nrclinonc.2012.9-c1

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  4 in total

1.  Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer.

Authors:  José Baselga; Mario Campone; Martine Piccart; Howard A Burris; Hope S Rugo; Tarek Sahmoud; Shinzaburo Noguchi; Michael Gnant; Kathleen I Pritchard; Fabienne Lebrun; J Thaddeus Beck; Yoshinori Ito; Denise Yardley; Ines Deleu; Alejandra Perez; Thomas Bachelot; Luc Vittori; Zhiying Xu; Pabak Mukhopadhyay; David Lebwohl; Gabriel N Hortobagyi
Journal:  N Engl J Med       Date:  2011-12-07       Impact factor: 91.245

2.  Breast Cancer: Blocking both driver and escape pathways improves outcomes.

Authors:  Mothaffar F Rimawi; C Kent Osborne
Journal:  Nat Rev Clin Oncol       Date:  2012-02-14       Impact factor: 66.675

Review 3.  Phosphatidylinositol 3-kinase and antiestrogen resistance in breast cancer.

Authors:  Todd W Miller; Justin M Balko; Carlos L Arteaga
Journal:  J Clin Oncol       Date:  2011-10-17       Impact factor: 44.544

Review 4.  Mechanisms of endocrine resistance in breast cancer.

Authors:  C Kent Osborne; Rachel Schiff
Journal:  Annu Rev Med       Date:  2011       Impact factor: 13.739
  4 in total
  3 in total

1.  Modeling the estrogen receptor to growth factor receptor signaling switch in human breast cancer cells.

Authors:  Chun Chen; William T Baumann; Robert Clarke; John J Tyson
Journal:  FEBS Lett       Date:  2013-08-28       Impact factor: 4.124

Review 2.  Combination of molecular-targeted drugs with endocrine therapy for hormone-resistant breast cancer.

Authors:  Shigehira Saji; Reiko Kimura-Tsuchiya
Journal:  Int J Clin Oncol       Date:  2015-02-24       Impact factor: 3.402

Review 3.  Evolving approaches to metastatic breast cancer patients pre-treated with anthracycline and taxane.

Authors:  Shigehira Saji
Journal:  BioDrugs       Date:  2013-10       Impact factor: 5.807
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.